Work

Assessing the effectiveness of camrelizumab plus anti-angiogenesis drug for the treatment of advanced liver cancer: a single‑center retrospective study

Year: 2025

Type: article

Study design: Observational Study

Source: Immunopharmacology and Immunotoxicology

DOI: 10.1080/08923973.2025.2513481

Authors: Fang Lu, Fanrong Wu

Institutions: Anhui Medical University, Chinese People's Liberation Army, Second Affiliated Hospital of Anhui Medical University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Award: G6572225119

OpenAlex ID: W4411351465

FWCI:

Cites: 49

Cited by:

Related to: 10